Researchers are looking at whether DPP4 inhibitors, a class of diabetes drugs, may be useful in treating COVID-19. There is some research indicating that DPP4 is directly involved in the cell adhesion and virulence of the virus causing COVID-19, which means inhibition of DPP4 may help treat this novel coronavirus. Read more